Objective: To determine the diameter changes of umbilical cord components in intrauterine growth restriction (IUGR) fetuses comparative with normal growth fetuses by using the ultrasonogram.
Material And Method: A cross sectional study was performed with 140 singleton pregnant women who was attended at Maternal-Fetal Medicine unit, Thammasat University Hospital between June, 2007 to May, 2009. The fetuses were between the gestational ages of 24 to 37 weeks at the time of data collection. Seventy pregnant women with IUGR fetuses and 70 pregnant women with normal growth (Appropriate for Gestational Age, AGA) fetuses were included. The sonogram of the umbilical cord, umbilical artery and umbilical vein diameter and circumference were obtained at the free loop of cord. Fetal weights were estimated by calculation in all cases. IUGR was defined as a fetus having an estimated fetal weight below the 10th percentile for the gestational age at time of the sonographic measurements.
Results: The mean age of the patients were 27.03 and 31.86 years in IUGR group and AGA group, respectively. The mean birth weight of the fetuses was 2153.60 +/- 386.13 gm and 3118.16 +/- 353.28 gm in IUGR fetuses and AGA fetuses, respectively. The result demonstrated the expected progressive increase of the umbilical cord circumference and diameter as a function of gestational age in AGA fetuses. These changes were not observed in the umbilical cord of IUGR fetuses. It was a contradictory finding that the measurement values from umbilical artery and umbilical vein IUGR fetuses were neither consistent nor correlated with fetal age.
Conclusion: The ultrasonogram of the umbilical cord component demonstrated the increasing of umbilical cord circumference and diameter along with an increasing of gestational age in the AGA fetuses. These findings might be useful for further studies, such as early screening or prediction of adverse pregnancy outcome for high risk women.
Download full-text PDF |
Source |
---|
Clin Proteomics
January 2025
Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 1, 00168, Rome, Italy.
Our objective is to determine the protein and complements constituents of Cord blood Platelet-rich plasma (CB-PRP), based on the hypothesis that it contains beneficial components capable of arresting or potentially decelerating the advancement of atrophic age-related macular degeneration (dry-AMD), with the support of radiomics. Two distinct pools of CB-PRP were assessed, each pool obtained from a total of 15 umbilical cord-blood donors. One aliquot of each pool respectively was subjected to proteomic analysis in order to enhance the significance of our findings, by identifying proteins that are shared between the two sample pools and gaining insights into the pathways they are associated with.
View Article and Find Full Text PDFHum Cell
January 2025
Department of Metabolism and Endocrinology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
The escalating diabetes prevalence has heightened interest in innovative therapeutic strategies for this disease and its complications. Human amniotic epithelial stem cells (HAESCs), originate from the innermost layer of the placenta closest to the fetus and express stem cell markers in the amniotic membrane's umbilical cord attachment area, which have garnered significant attention. This article critically examines emerging research advancements and potential application values of hAESCs in treating diabetes and its complications.
View Article and Find Full Text PDFOphthalmic Plast Reconstr Surg
January 2025
Kahana Oculoplastic and Orbital Surgery, Livonia, Michigan.
Loss of periocular skin due to cancer, trauma, or surgery is a major reconstructive challenge; resultant tissue contracture can cause eyelid malposition with poor functional and aesthetic outcomes. We describe the successful use of cryopreserved umbilical cord amniotic membrane as a wound covering and scaffold for periorbital anterior lamellar defects. This is a retrospective case series of 4 patients (mean 21 years, range 9-30 years, 3 male) who underwent periocular reconstruction with umbilical cord amniotic membrane of 9 different sites.
View Article and Find Full Text PDFFront Pharmacol
December 2024
Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Introduction: MRTX1133 is a selective and reversible small molecule inhibitor of KRAS (G12D), which significantly delays the progression of solid tumors. However, no study on the absorption, distribution, and excretion of MRTX1133.
Methods: A fast ultra-high performance liquid chromatography-tandem quadrupole mass spectrometry method was developed for the determination of MRTX1133 in rat plasma, tissue homogenate, and urine.
Exp Hematol Oncol
January 2025
Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, 400037, China.
Background: Due to the lack of effective treatment options, the prognosis of patients with relapsed/refractory acute myeloid leukemia (R/R AML) remains poor. Although chimeric antigen receptor (CAR)-T-cell therapy has shown promising effects in acute lymphoblastic leukemia (ALL) and lymphoma, its application in R/R AML is limited by "off-target" effects, which lead to severe bone marrow suppression and limit its clinical application. CAR-natural killer (NK) cells not only exhibit antitumor effects but also demonstrate increased safety and universality.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!